pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Apr 28·2 min read
save

STAT+: A giant question looms over GOP’s new Medicaid work requirements

Coverage losses tied to Medicaid work requirements may not be tracked in every states.

Apr 28, 2026·read at STAT ↗

STAT PlusPolitics A giant question looms over GOP’s new Medicaid work requirements The law doesn’t require states to report on implementing work requirements. Will we know their consequences? Manage alerts for this article Email this article Share this article By John WilkersonApril 28, 2026 John Wilkerson, a Washington correspondent, is the author of D.C.

Diagnosis, a twice-weekly newsletter about the politics and policy of health and medicine. John Wilkerson[email protected]John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C.

Diagnosis newsletter. WASHINGTON — Democrats and Republicans are at odds over a consequential health care policy embedded in last year’s tax cut law. Democrats say the law’s Medicaid work requirements will create red tape that leads to people losing their coverage.

Republicans say the measure encourages work.Advertisement But because the law doesn’t require states to report on the implementation of this massive change to Medicaid, we may never get a detailed account of how the policy is working. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%!

2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In CMS, Medicaid, Policy, public health, STAT+ Submit a correction requestReprints John Wilkerson Washington Correspondent John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C.

Diagnosis newsletter. Newsletter The latest updates in federal health agencies, research institutes, and U.S. policy Recommended Health Care Inc.

Newsletter April 27, 2026 STAT Plus: An insider reveals the real goals of prior authorization D.C. Diagnosis April 23, 2026 STAT Plus: RFK Jr. backs off some MAHA issues Advertisement Politics April 22, 2026 STAT Plus: Federal test of AI prior authorization is delaying care for seniors, report says Biotech April 21, 2026 STAT Plus: Insurers refuse to join Medicare pilot offering weight loss drugs to seniors at steep discount Business April 21, 2026 STAT Plus: UnitedHealth earnings beat expectations in the first quarter, but hurdles persist Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
444 words · retrieved Apr 30
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Obesity

related stories

  • Apr 30Smog from wildfires increasingly harmful, data showSTAT
  • Apr 30Updated: Early sales of Lilly’s obesity pill appear to trail Novo’sEndpoints
  • Apr 30STAT+: New obesity tool aims to predict risk of 18 serious complicationsSTAT
  • Apr 29STAT+: A patent win for Pfizer and BridgeBioSTAT
  • Apr 28STAT+: FDA launches effort to speed up clinical trials, using AISTAT